P. Esser et al., THE SIGNIFICANCE OF VITRONECTIN IN PROLIFERATIVE DIABETIC-RETINOPATHY, Graefe's archive for clinical and experimental ophthalmology, 232(8), 1994, pp. 477-481
Vitronectin, an integrin-binding a-1-glycoprotein with potent cell-adh
esion and proliferation-mediating properties, has been shown to be inc
orporated in surgically removed membranes from patients with prolifera
tive vitreoretinopathy (PVR), proliferative diabetic retinopathy (PDR)
and macular pucker. Therefore we developed an ELISA technique to quan
tify levels of vitronectin in human vitreous and plasma samples in ord
er to be able to evaluate the significance of vitronectin in these dif
ferent vitreoretinal diseases. Our results indicate a significant incr
ease of vitronectin in all proliferative disorders except idiopathic m
acular pucker. Adjustment of all probes to equal total protein content
yielded a significant increase only in PDR (type II diabetes). Plasma
samples demonstrated a significant increase of vitronectin in patient
s with type II diabetes suffering from PDR. Therefore, breakdown of th
e blood-retina barrier appears to be the most likely explanation for t
he increased levels of vitronectin in the vitreous. Our results indica
te that vitronectin may not only be involved in the regulation of epir
etinal membrane formation at significantly higher levels in patients w
ith type II diabetes, but the increase of vitronectin in diabetic plas
ma may also help to explain the pathological alteration of the coagula
tion cascade in diabetics.